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Abstract
Objectives:  To  summarize  the  main  clinical  entities  associated  with  fever  without  source  (FWS)
in infants,  as  well  as  the  clinical  management  of  children  with  occult  bacteremia,  emphasizing
laboratory  tests  and  empirical  antibiotics.
Sources:  A  non-systematic  review  was  conducted  in  the  following  databases  --  PubMed,  EMBASE,
and SciELO,  between  2006  and  2015.
Summary  of  the  ﬁndings:  The  prevalence  of  occult  bacteremia  has  been  decreasing  dramati-
cally in  the  past  few  years,  due  to  conjugated  vaccination  against  Streptococcus  pneumoniae
and Neisseria  meningitidis.  Additionally,  fewer  requests  for  complete  blood  count  and  blood
cultures have  been  made  for  children  older  than  3  months  presenting  with  FWS.  Urinary  tract
infection is  the  most  prevalent  bacterial  infection  in  children  with  FWS.  Some  known  algorithms,
such as  Boston  and  Rochester,  can  guide  the  initial  risk  stratiﬁcation  for  occult  bacteremia  in
febrile infants  younger  than  3  months.
Conclusions:  There  is  no  single  algorithm  to  estimate  the  risk  of  occult  bacteremia  in  febrile
infants, but  pediatricians  should  strongly  consider  outpatient  management  in  fully  vaccinated
infants older  than  3  months  with  FWS  and  good  general  status.  Updated  data  about  the  incidence
of occult  bacteremia  in  this  environment  after  conjugated  vaccination  are  needed.
© 2015  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.
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Manejo  atual  da  bacteremia  oculta  do  lactente
Resumo
Objetivos:  Listar  as  principais  entidades  clínicas  associadas  a  quadros  de  febre  sem  sinais  local-
izatórios  (FSSL)  em  lactentes,  bem  como  o  manejo  dos  casos  de  bacteremia  oculta  com  ênfase
na avaliac¸ão  laboratorial  e  na  antibioticoterapia  empírica.
Fonte  dos  dados: Foi  realizada  revisão  não  sistemática  da  literatura  nas  bases  de  dados  PubMed,
EMBASE  e  Scielo  no  período  de  2006  a  2015.
Síntese  dos  dados: A  ocorrência  de  bacteremia  oculta  vem  diminuindo  sensivelmente  em
lactentes com  FSSL,  principalmente  devido  à  introduc¸ão  da  vacinac¸ão  conjugada  contra  Strep-
tococcus pneumoniae  e  Neisseria  meningitidis  nos  últimos  anos.  Juntamente  disso,  uma  reduc¸ão
constante  na  solicitac¸ão  de  hemogramas  e  hemoculturas  em  lactentes  febris  acima  de  3  meses
vem sendo  observada.  A  infecc¸ão  do  trato  urinário  é  a  infecc¸ão  bacteriana  mais  prevalente  no
paciente febril.  Algoritmos  consagrados,  como  o  de  Boston  e  Rochester,  podem  guiar  a  decisão
clínica inicial  para  estimar  o  risco  de  bacteremia  em  lactentes  entre  um  e  3  meses  de  vida.
Conclusões:  Não  há  esquema  padronizado  para  a  estimativa  do  risco  de  bacteremia  oculta  em
lactentes febris,  porém  deve-se  considerar  fortemente  o  manejo  ambulatorial  de  lactentes
acima de  3  meses  com  FSSL  em  bom  estado  geral  e  com  esquema  vacinal  completo.  São
necessários  dados  atualizados  sobre  a  incidência  de  bacteremia  oculta  em  crianc¸as  vacinadas
em nosso  meio.
©  2015  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os  direitos
reservados.
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ever  without  source  (FWS)  is  one  of  the  major  diag-
ostic  challenges  for  the  emergency  service  pediatrician.
pproximately  20%  of  febrile  children  do  not  have  an
nitially-established  etiological  diagnosis,  and  around  20%
f  emergency  consultations  in  children  between  2  and  24
onths  of  age  are  due  to  fever.1,2 In  this  scenario,  it  is
ssential  to  perform  a  rapid  diagnosis  of  children  with  possi-
le  severe  bacterial  infection  (SBI),  who  require  immediate
ntibiotic  therapy.  SBIs  include  sepsis/septic  shock,  occult
acteremia  (OB),  bacterial  meningitis,  pneumonia,  urinary
ract  infection,  bacterial  gastroenteritis,  osteomyelitis,  and
eptic  arthritis.3
The  evaluation  of  febrile  infants  is  even  more  of  a  con-
ern  considering  the  relative  immaturity  of  the  immune
ystem  in  the  ﬁrst  3  months  of  life.  Factors  that  may  increase
he  risk  of  SBI  in  infants  include  reduced  macrophage
nd  opsonization  activity,  in  addition  to  lower  neutrophil
ctivity.4 While  it  is  a  consensus  that  early  introduction  of
ntibiotics  leads  to  a  favorable  outcome  in  children  with
WS  in  poor  general  status  and  with  toxemia,  the  manage-
ent  of  children  in  good  general  status  is  still  a  matter  of
uch  discussion,  in  whom  the  risk  of  SBI,  particularly  OB,  is
ery  low.5
Although  several  authors  have  studied  the  combination
f  clinical  and  laboratory  parameters  for  risk  stratiﬁcation
f  SBI  in  febrile  infants,  to  date  there  is  no  single  test  or  set
f  tests  that  is  able  to  detect  infants  with  SBI  with  optimal
6ensitivity. This  article  aimed  to  describe  the  main  clini-
al  conditions  associated  with  FWS  in  infants  and  to  analyze
he  methods  of  laboratory  evaluation  of  fever  in  this  age
roup.
e
a
dain entities associated with FWS
iral  infections
iral  infections  are  common  causes  of  FWS  in  infants,  and
any  patients  are  treated  with  antibiotics  in  this  situation,
espite  the  lack  of  evidence  for  bacterial  infections.  Viruses
nd  bacteria  interact  with  different  pattern-recognition
eceptors  in  circulating  leukocytes,  triggering  different  spe-
iﬁc  immune  responses.7 In  a  study  involving  75  children  with
WS,8 one  or  more  viruses  were  detected  by  polymerase
hain  reaction  in  76%  of  the  cases;  among  children  with
ever  and  a  probable  deﬁned  infection  source,  this  percent-
ge  was  40%,  and  among  the  afebrile  children  in  the  control
roup,  in  35%  of  cases.  The  most  often  identiﬁed  viruses
ere  adenovirus,  herpes  virus  type  6,  enteroviruses,  and
arechovirus.
ccult  bacteremia
B  is  deﬁned  as  a positive  blood  culture  in  a  patient  with
WS.6 The  prevalence  of  OB  has  dramatically  decreased  in
ecent  years,  on  account  of  conjugate  bacterial  vaccines.  In
he  pre-vaccine  era,  the  prevalence  of  OB  was  2.4--11.6%  in
hildren  with  FWS,  and  pneumococcus  was  the  main  disease-
ausing  agent  (50--90%  of  cases).9,10 At  the  age  of  1  week  to
 months  of  age,  Escherichia  coli  represents  56%  of  bac-
eremia  cases,  with  group  B  Streptococcus  as  the  second
ost  prevalent  agent,  representing  21%  of  cases.11
A  recent  retrospective  cohort  study12 evaluated  201
pisodes  of  pneumococcal  OB  in  infants  with  a  median
ge  of  20.5  months.  The  cases  due  to  PCV7  serotype
ecreased  from  82.2%  to  19.5%  after  vaccination,  with  most
r
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fOccult  bacteremia  in  infants  
cases  occurring  after  the  vaccination  period  due  to  PCV19A
serotype.  The  recent  introduction  of  the  pneumococcal  13-
valent  vaccine  will  certainly  reduce  these  ﬁndings.
A  blood  culture  sample  is  often  requested  in  febrile
infants  with  suspected  OB.  In  a  recent  multicenter  prospec-
tive  study,13 bacterial  growth  was  found  in  1.5%  of  65,169
blood  cultures,  with  pneumococcus  being  the  most  fre-
quently  isolated  microorganism  (27.3%  of  cases);  in  this
study,  47.1%  of  the  children  were  younger  than  1  year  old.
Studies  have  also  conﬁrmed  that  there  is  a  signiﬁcant
reduction  in  requests  for  blood  count  in  febrile  infants  when
the  immunization  schedule  is  complete.  Zeretzke  et  al.14
assessed  infants  between  6  and  24  months  with  FWS  >  39 ◦C
and  found  that,  prior  to  protocol  implementation  to  verify
the  infants’  immunization  status,  100%  were  submitted  to
blood  collection  for  complete  blood  count,  with  this  rate
reduced  by  58%  when  the  pneumococcal  and  meningococcal
vaccination  status  was  complete.
Urinary  tract  infection  (UTI)
This  is  the  most  prevalent  bacterial  infection  in  febrile
infants,  corresponding  to  5--7%  of  the  cases  of  FWS.15 In
recent  years,  several  authors  have  studied  the  presence
of  factors  that  increase  the  risk  of  UTI  in  certain  patient
groups.  However,  despite  these  ﬁgures,  UTI  in  infants  with
FWS  is  probably  underdiagnosed,  since  the  majority  of
patients  present  with  nonspeciﬁc  symptoms  that  are  com-
mon  to  several  other  acute  infections.  The  occurrence  of
UTI  in  childhood  is  associated  with  several  long-term  kidney
complications,  such  as  hypertension,  pre-eclampsia,  and
renal  failure;  renal  scarring  may  be  present  in  approximately
15%  of  children  after  a  ﬁrst  episode  of  UTI.16,17
In  2011,  the  American  Academy  of  Pediatrics  published
updated  guidelines  concerning  the  diagnosis,  treatment,
and  complementary  investigation  of  patients  with  UTI  in
order  to  reduce  the  chances  of  renal  scarring  and  future
renal  injury.18 This  article  described  an  initial  investigation
algorithm  to  estimate  the  risk  of  UTI  in  febrile  children
aged  2--24  months,  based  on  clinical  and  demographic
characteristics.19 The  main  risk  factor  in  febrile  boys  was  the
absence  of  prior  circumcision.  In  boys,  it  is  recommended  to
screen  for  UTI  if  one  or  more  of  the  following  risk  factors  are
present  (UTI  risk  1--2%)  --  white  ethnicity,  temperature  above
39 ◦C,  fever  for  more  than  24  h,  and  absence  of  other  infec-
tion  sources.  In  girls,  the  factors  include  white  ethnicity,  age
<12  months,  temperature  >39 ◦C,  fever  for  more  than  48  h,
and  no  apparent  source  of  infection.
UTI  diagnosis  requires  the  presence  of  leukocyturia  and
at  least  50,000  colonies/mL  of  a  single  uropathogen  in  an
adequately  collected  urine  sample.  It  is  recommended  to
collect  the  sample  only  by  catheterization  in  children  with-
out  sphincter  control,  due  to  the  high  risk  of  contamination
and  false  positive  results  in  children  from  which  urine  was
collected  through  sample  collection  bags.  Suprapubic  aspi-
ration  should  be  reserved  for  exceptional  cases,  and  has
been  less  and  less  used  in  clinical  practice.  However,  the
analysis  of  urinary  sediment  (urine  test  I)  and/or  urinary
strip  is  widely  used  in  emergency  for  rapid  diagnosis  of
UTI.  A  recent  systematic  review  found  no  signiﬁcant  differ-
ences  between  the  information  obtained  by  both  methods,
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ecommending  the  initial  treatment  of  children  at  risk  for
TI  if  there  is  leukocyturia  or  alterations  in  urinary  strip
positive  leukocyte  esterase  and/or  positive  nitrite)  until  the
onﬁrmation  can  be  obtained  by  urine  culture  test.20
aboratory diagnosis
t  is  a  consensus  that  the  likelihood  of  occult  bacteremia
nd  SBI  decreased  sharply  after  the  introduction  of  the
onjugate  vaccine  in  the  immunization  schedule.  Thus,  the
utpatient  management  of  children  with  FWS  can  be  a  safe
nd  less  costly  alternative  in  those  at  low  risk  for  SBI.6
After  the  introduction  of  the  conjugate  vaccine  against
aemophilus  inﬂuenzae  type  B,  the  risk  of  OB  decreased  to
.5--3%;  after  the  introduction  of  the  7-valent  pneumococ-
al  vaccination,  this  risk  further  decreased  to  0.5--1%.21 The
igher  immunization  coverage  to  other  serotypes  of  Strepto-
occus  pneumoniae  with  the  13-valent  vaccine  can  further
educe  these  ﬁgures,  so  that  infants  in  good  general  sta-
us  probably  will  not  require  laboratory  tests  in  order  to
stimate  OB  risk.5,22,23 In  a  recent  analysis  of  591  children
etween  3  and  36  months  with  FWS  who  were  in  good  general
tatus  on  admission  and  were  submitted  to  laboratory  evalu-
tion  with  blood  cell  count  (CBC),  C-reactive  protein  (CRP),
r  procalcitonin,  only  1%  had  OB,  with  half  of  the  cases  due
o  OB  caused  by  S.  pneumoniae, and  none  of  these  children
ad  been  immunized  against  pneumococcus.1 Based  on  the
bovementioned  ﬁndings,  there  have  been  changes  in  recent
ears  regarding  the  management  of  infants  with  FWS.24
In  1993,  Baraff  et  al.25 published  guidelines  for  evaluation
f  infants  with  FWS  between  3  and  36  months  of  age;  these
ecommendations  were  revised  in  2008  with  the  inclusion
f  urinalysis  for  infants  at  risk  of  UTI  (e.g., uncircumcised
oys),  questioning  the  usefulness  of  laboratory  assessment
ith  blood  count  in  fully  immunized  children  in  good  general
tatus.23 Neutropenia  (neutrophil  count  <1500/mm3),  con-
idered  a  risk  factor  for  OB  in  infants  with  FWS  according  to
he  criteria  of  Rochester  (Table  1),  has  recently  been  stud-
ed  in  non-cancer  patients.  In  a  recent  case-control  study
ith  patients  older  than  3  months  with  FWS,  neutropenia
as  not  a  risk  factor  for  OB,  which  puts  in  doubt  the  prompt
ndication  of  antibiotics  for  neutropenic  infants  with  FWS.26
n  infants  between  4  and  12  weeks  old,  classically  used  algo-
ithms,  such  as  Boston,  Baraff,  and  Rochester,  help  in  the
nitial  decision-making  regarding  antibiotic  therapy  and  con-
uct,  as  described  in  Table  1.  Patients  with  the  laboratory
riteria  described  below  can  be  considered  as  low  risk  for  OB
nd  undergo  outpatient  management,  returning  after  24  h
or  reassessment.
Over  the  years,  particularly  after  the  introduction  of
onjugate  bacterial  vaccines,  blood  count  requests  in  the
valuation  of  febrile  infants  have  decreased  systematically.
 recent  study  revealed  that  58.6%  of  patients  with  FWS
valuated  in  the  emergency  services,  up  to  3  years  old  and
n  good  general  status,  did  not  have  the  test  requested;  in
act,  blood  count  was  performed  only  in  20%  of  patients.27
Blood  culture  request  is  limited  by  the  low  test  positivity
nd  the  time  it  takes  until  the  results  are  known.  Infants  with
WS  and  bacteremia  have  greater  risk  for  the  development
f  focal  infections  such  as  meningitis  (approximately  10%);
hus,  identifying  a  positive  blood  culture  at  an  early  stage
S64  Filho  EM,  de  Carvalho  WB
Table  1  Main  algorithms  used  in  risk  stratiﬁcation  of  infants  with  FWS  up  to  90  days  of  life.
Criterion  Boston  Philadelphia  Rochester
Age  (days)  28--89  29--56  0--60
Temperature  (◦C) ≥38.0 ≥38.2  ≥38.0
Leukogram  (leukocytes/mm3)  5000--20,000  <15,000  5000--15,000
Band cells  Not  considered  Neutrophilic  index  <0.2
(band  cells:  neutrophils)
<1500/mm3
Urinalysis  <10  leukocytes/ﬁeld  <10  leukocytes/ﬁeld  <10  leukocytes/ﬁeld
Liquor <10  leukocytes/mm3 <8  leukocytes/mm3 Only  if  leukopenia  or
leukocytosis
Fecal leukocyte  count  If  diarrhea  If  diarrhea  If  diarrhea
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an  prevent  severe  bacterial  complications.28 The  accept-
ble  number  of  contaminated  blood  cultures  (for  instance,
ith  coagulase-negative  Staphylococcus  species)  is  3--4%,
hich  may  result  in  hospitalizations,  additional  costs,  and
nnecessary  antibiotic  therapy.29
Several  authors  have  attempted  to  develop  scores  for
BI  diagnosis  and  thus  avoid  the  unnecessary  use  of  empir-
cal  antibiotic  therapy  for  children  with  FWS.  The  recently
escribed  Lab-score  uses  independently  associated  param-
ters  with  the  occurrence  of  SBIs,  with  different  weights
ccording  to  the  odds  ratio  obtained  for  each  variable  in
he  univariate  analysis  of  the  original  study.  Based  on  the
ombined  determination  of  procalcitonin  and  C-reactive
rotein,  in  addition  to  the  results  of  the  urinary  tape  anal-
sis,  the  score  can  have  results  from  0  to  9;  a  cutoff  of  3
howed  94%  sensitivity  and  78%  of  speciﬁcity  for  the  diag-
osis  of  SBIs  in  children  between  7  days  and  36  months  of
ife.30 The  adequate  use  of  this  tool  can  reduce  up  to  26.5%
he  prescription  of  antibiotics  in  children  with  FWS,  as  shown
n  a  recent  clinical  trial.3
Traditionally,  according  to  the  Baraff  criteria,  infants
ith  FWS  and  more  than  15,000  leukocytes/mm3 in  the
lood  count  had  an  increased  risk  for  OB.  However,  recent
vidence  demonstrates  the  limited  diagnostic  value  of  the
eukogram  to  demonstrate  the  presence  of  SBI  in  febrile
nfants.31 CRP  has  slightly  better  sensitivity  than  the  leuko-
ram  for  this  purpose,  but  also  has  limitations  to  indicate
ntibiotic  therapy  in  febrile  patients.  Recently,  procalci-
onin  (PCT)  has  been  studied  and  identiﬁed  as  a  reliable
BI  marker  in  febrile  children,  which  was  veriﬁed  at  the
ifferentiation  between  bacterial  and  viral  meningitis  and
etween  pyelonephritis  and  cystitis.32,33 PCT  levels  corre-
ate  with  the  bacterial  infection  invasiveness  and  have  more
avorable  kinetics,  showing  an  increase  within  the  ﬁrst  six
ours  of  fever  when  compared  to  the  CRP.  This  ﬁnding  may
ave  particular  importance  in  febrile  young  infants,  as  they
re  more  likely  to  develop  SBI  and  are  usually  taken  to  the
mergency  room  after  just  a  few  hours  of  fever.34
In  a  study  of  1112  infants  with  FWS,  SBI  was  diagnosed
n  2.1%  of  cases.  PCT  values  >0.5  ng/mL  were  the  only  inde-
endent  risk  factors  for  SBI,  with  an  odds  ratio  of  21.69.
n  another  study  with  868  infants  with  FWS,  in  good  status
t  admission,  the  sensitivity  of  the  PCT  for  the  same  cutoff
alue  of  0.9  ng/mL  was  86.7%,  with  a  speciﬁcity  of  90.5%
hen  compared  to  CRP,  whose  cutoff  value  of  91  mg/L  had
 sensitivity  of  33.3%  and  speciﬁcity  of  95.9%.35
g
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rIn  all  patients If  respiratory  symptoms
reatment of OB in febrile infants
ccording  to  the  data  presented  above,  the  recommenda-
ion  of  a  single  protocol  for  the  evaluation  and  treatment  of
ebrile  infants  is  not  possible.6 The  management  of  fever
n  newborns  is  outside  the  scope  of  this  article,  but  it
nvolves  aggressive  conduct,  with  the  collection  of  all  cul-
ures,  including  cerebrospinal  ﬂuid  (CSF),  as  well  as  hospital
dmission  and  parenteral  antibiotic  therapy  until  the  ﬁnal
esults  are  obtained.
For  infants  between  4  and  12  weeks  of  age  with  FWS,
he  collection  of  blood  count,  blood  culture,  and  inﬂam-
atory  markers  such  as  CRP  and  PCT  are  recommended,  as
ell  as  urinalysis  with  sample  obtained  by  catheterization
r  suprapubic  aspiration,  for  cases  of  exception.  Hospital-
zation  is  recommended  in  cases  of  UTI,  with  cefuroxime
150  mg/kg/day)  or  ceftriaxone  (50--100  mg/kg/day)  pre-
cription;  in  febrile  infants  at  risk  for  OB,  according  to
he  criteria  shown  in  Table  1, CSF  collection  is  recom-
ended,  as  well  as  hospital  admission  with  ceftriaxone
50--100  mg/kg/day)  until  the  culture  results  are  obtained,  if
here  is  no  meningitis.  It  is  essential  to  reassess  patients  with
WS,  who  should  be  treated  on  an  outpatient  basis  within
4  h,  if  they  are  not  at  risk  for  OB.
In  infants  aged  between  3  and  36  months  of  life,  the
mpact  of  conjugate  vaccination,  as  previously  described,
akes  it  unnecessary  to  collect  blood  count  and  blood  cul-
ures  in  patients  with  good  general  status.  Urine  collection
hould  be  considered  according  to  the  abovementioned  fac-
ors,  especially  in  febrile  girls  younger  than  24  months  and
ncircumcised  boys  younger  than  12  months  with  FWS.18
outine  chest  X-rays  are  not  recommended  in  patients  at
his  age  group  with  no  respiratory  signs  or  symptoms,  even
ttenuated  ones.  Infants  in  poor  general  status  and/or  with
oxemia  should  undergo,  in  addition  to  blood  count,  blood
ulture,  CRP  or  PCT,  CSF  collection,  and  hospital  admission
ith  ceftriaxone,  at  the  same  aforementioned  doses,  until
ulture  results  are  obtained  and/or  fever  resolution.
onclusions
ever  remains  an  important  cause  of  consultation  in  emer-
ency  services  in  children  up  to  3  years  old,  and  the  request
f  multiple  laboratory  tests  for  initial  assessment  is  still  fre-
uent,  as  well  as  antibiotic  therapy,  even  in  children  at  no
isk  for  OB  and  with  no  presumed  bacterial  infection.  Over
11
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
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the  past  few  years,  mainly  due  to  the  introduction  of  con-
jugate  vaccines  in  the  Brazilian  vaccination  schedule,  it  is
possible  that,  as  in  countries  where  this  vaccination  has  been
applied  for  a  longer  period  of  time,  a  drastic  reduction  has
occurred  in  the  prevalence  of  OB  in  febrile  infants.  Given  the
current  recommendations,  blood  count  and  blood  culture
collection  should  not  be  routinely  performed  in  infants  older
than  3  months  with  fever  and  in  good  general  status.  Stud-
ies  are  necessary  in  Brazil  country  to  conﬁrm  the  decrease
in  cases  of  OB  in  infants  in  the  post-vaccine  era.
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